Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.9950
+0.0360 (3.75%)
At close: Aug 7, 2026, 4:00 PM EDT
0.969926
-0.0251 (-2.52%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Filana Therapeutics Employees
As of December 31, 2025, Filana Therapeutics had 20 total employees, including 17 full-time and 3 part-time employees. The number of employees decreased by 10 or -33.33% compared to the previous year.
Employees
20
Change (1Y)
-10
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,114,000
Market Cap
48.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 20 | -10 | -33.33% | 17 | 3 |
| Dec 31, 2024 | 30 | 1 | 3.45% | 30 | 0 |
| Dec 31, 2023 | 29 | 3 | 11.54% | 29 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 26 | 0 |
| Dec 31, 2021 | 24 | 13 | 118.18% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Metagenomi Therapeutics | 118 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| Mereo BioPharma Group | 39 |
| eXoZymes | 32 |
| Instil Bio | 17 |
| Context Therapeutics | 15 |
FLNA News
- 11 days ago - Filana Therapeutics Earnings release: Q2 2026 - Filings
- 11 days ago - Filana Therapeutics Quarterly report: Q2 2026 - Filings
- 11 days ago - Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - Filana Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - Filana Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Filana Therapeutics resumed with Buy at Maxim on rebranding, strategic pivot - TheFly
- 2 months ago - Filana Therapeutics resumed with a Buy at Maxim - TheFly
- 3 months ago - Filana Therapeutics Reports Q1 2026 Financial Results and Business Update - GlobeNewsWire